Shield is a DNA blood test and therefore not suitable for mass population screening (too expensive).
The article states in the first paragraph that Guardant are keenly investing in possibly ways to raise compliance among test resistant people.
You provide more evidence that the global race to find a way to increase colorectal cancer screening is huge. There is a lot of money to be made, and Rhythm's Colostat is winning!
- Forums
- ASX - By Stock
- Increasing Screening Compliance for Colorectal Cancer
Shield is a DNA blood test and therefore not suitable for mass...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
Add RHY (ASX) to my watchlist
|
|||||
Last
4.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.68M |
Open | High | Low | Value | Volume |
4.7¢ | 4.8¢ | 4.2¢ | $9.183K | 197.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 68500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 51425 | 0.047 |
2 | 52542 | 0.043 |
1 | 47470 | 0.042 |
2 | 140586 | 0.041 |
2 | 524995 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 68500 | 1 |
0.056 | 20000 | 1 |
0.065 | 19644 | 2 |
0.066 | 79998 | 1 |
0.070 | 340394 | 2 |
Last trade - 14.17pm 02/08/2024 (20 minute delay) ? |
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
GML
Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
RHY (ASX) Chart |